Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00DXH
|
|||
| Former ID |
DIB015109
|
|||
| Drug Name |
LYS-6KAKT1
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
Eli Lilly & Co
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034531) | |||
| REF 2 | DOI: 10.1016/S1359-6349(10)71767-5 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.